INS and type 2 diabetes mellitus: The tacrolimus-treated animals in this study exhibited the deterioration of pancreatic β cells and an insufficiency in the secretion of insulin, thus meeting the criteria proposed by the ADA for the diagnosis of type 2 diabetes and NODAT.29 The current model is low in cost, thus contrasting with expensive spontaneous models.